PDCD1 and myocarditis: Finally, we studied the vaccination by itself, and in combination with other immune-based therapies that have myocarditis as a side effect, e.g., immune checkpoint inhibition in cancer therapy, in PD-1+/+ control mice and PD-1 knockout (PD-1−/−) mice [43,44,45,46].